Biomass-derived micro/nanomaterials have been broadly used as supercapacitor electrodes due to their natural abundance, low cost, and adjustable pore structures (Shaker et al
[1] [2] The pivotal clinical trials evaluating tirzepatide for type 2 diabetes (SURPASS programme) and obesity (SURMOUNT programme) did not identify hot flushes as a significant treatment-emergent adverse event
After reconstitution with bacteriostatic water, the solution should be stored at 2 to 8 degrees Celsius and used within 28 days
J., Startseva, N., Unseld, A., & Haupt, A
Tirzepatide is a dual receptor co-agonist that also activates GLP-1 but goes a step further by targeting a second hormone called GIP (glucose-dependent insulinotropic polypeptide)
Potential cognitive benefits under investigation: Improved learning and memory consolidation Enhanced neuroplasticity and synaptic function Reduced accumulation of pathological proteins (amyloid-beta, tau) Protection against vascular damage affecting brain tissue Clinical trials exploring GLP-1 receptor agonists for Alzheimer's disease and other neurodegenerative conditions are ongoing, but evidence in humans remains inconclusive and mixed